A61P 27 - Drugs for disorders of the senses

Patents for A61P 27 - Drugs for disorders of the senses (53,017)
11/2011
11/17/2011	US20110281957 Enhanced bioactive formulations of resveratrol
11/17/2011	US20110281951 Compositions and methods for treating amyloidosis
11/17/2011	US20110281946 Polymeric -based composition
11/17/2011	US20110281901 Pharmaceutical compositions and methods of making same
11/17/2011	US20110281897 Heterocyclic compounds and their uses
11/17/2011	US20110281885 Therapeutic agents useful for treating pain
11/17/2011	US20110281882 Compositions and Methods for Treating, Controlling, Reducing, or Ameliorating Inflammatory Pain
11/17/2011	US20110281859 Novel heterocyclic compounds as metap-2 inhibitors
11/17/2011	US20110281846 Bridged bicyclic aryl and bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors
11/17/2011	US20110281844 Non-imidazole alkylamines as histamine h3-receptor ligands and their therapeutic applications
11/17/2011	US20110281843 Substituted indazole derivatives active as kinase inhibitors
11/17/2011	US20110281840 N-substituted saturated heterocyclic sulfone compounds with cb2 receptor agonistic activity
11/17/2011	US20110281832 Organic compounds
11/17/2011	US20110281822 Aromatic compounds having sphingosine-1-phosphonate (s1p) receptor activity
11/17/2011	US20110281809 Methods and compositions for rapid treatment of otitis externa
11/17/2011	US20110280972 Preparation for the treatment of tinnitus
11/17/2011	US20110280964 Composition And Method of Treating Hearing Loss
11/17/2011	US20110280955 Nutritional Supplements For 50+ Individuals For Improving Vitality, Immunity, Eye And Bone Health
11/17/2011	US20110280952 Platelet Lysate and Bioadhesive Compositions Thereof for the Treatment of Mucositis
11/17/2011	US20110280929 Sirna of nf-kb p105 for inhibiting cell proliferation and migration and a composition comprising same
11/17/2011	US20110280909 Method and system for effecting changes in pigmented tissue
11/17/2011	US20110280876 Mutated netrin - 4, fragments thereof and their use as medicines
11/17/2011	US20110280830 Albumin Fusion Proteins
11/17/2011	US20110280829 Low Molecular Weight Sulphated Polysaccharides as Candidates for Anti-Angiogenic Therapy
11/17/2011	US20110280808 Novel Compounds for the Treatment of Diseases Associated with Amyloid or Amyloid-Like Proteins
11/17/2011	US20110280799 Nanocells for diagnosis and treatment of diseases and disorders
11/17/2011	CA2835596A1 Benzo- or pyrido-imidazole derivative
11/16/2011	EP2386545A1 Heteroaryl ureas containing nitrogen hetero-atoms as P38 kinase inhibitors
11/16/2011	EP2386299A2 1-Amino-Alkylcyclohexane derivatives for the treatment of cochlear tinnitus
11/16/2011	EP2385839A2 Therapeutic compositions for treatment of corneal disorders
11/16/2011	EP2385835A1 Use of deuterium oxide for treating viral diseases of the eye
11/16/2011	CN102245166A Ophthalmic administration of a composition including brimonidine as a mist
11/16/2011	CN102242154A Liquid fermentation method for producing paecilomyces cicadae mycelia and application of culture product
11/16/2011	CN102242148A Recombinant vector, fibroin film modified by transgenic marrow stromal cells and application thereof
11/16/2011	CN102242070A Method for artificially culturing paecilomyces cicadae and application of culturing product thereof
11/16/2011	CN102242069A Paecilomycescicadae (Miq.)Samson and application thereof
11/16/2011	CN102240388A Ginger extract and preparation method and applications thereof
11/16/2011	CN102240366A Quality detection method for preparation for vision rehabilitation
11/16/2011	CN102240357A Medicament for treating tinnitus and preparation method thereof
11/16/2011	CN102240339A Traditional Chinese medicine composition for treating glaucoma
11/16/2011	CN102240292A 增强型比马前列素眼用溶液 Enhanced bimatoprost ophthalmic solution
11/16/2011	CN102240278A Methods, assays and compositions for treating retinol-related diseases
11/16/2011	CN102058845B Medicinal composition for treating macular degeneration
11/16/2011	CN101978968B Medicament for treating tympanitis
11/16/2011	CN101797314B Medicinal composition for treating adolescent myopia and preparation method thereof
11/16/2011	CN101780037B Dipyridamole self-emulsifying medicament administration system and preparation method thereof
11/16/2011	CN101756906B Pharmaceutical composition of cefcapene pivoxil hydrochloride granules and preparation method thereof
11/16/2011	CN101461859B Method for controlling quality of anti-inflammation antibacterial medicament
11/16/2011	CN101411833B Dragon's blood extract as well as preparation method and application thereof
11/16/2011	CN101357144B Selaginella uncinata extraction, its preparation method and application
11/16/2011	CN101249129B Chinese medicine extract combination and medicine use thereof
11/16/2011	CN101175487B Pharmaceutical use of ebselen
11/16/2011	CN101128193B Anti-radical agents
11/16/2011	CN101102989B Substituted cyclopentanes or cyclopentanones for the treatment of ocular hypertensive conditions
11/15/2011	US8058445 Substituted pyridinecarboxamides for the treatment of cancer
11/15/2011	US8058426 Phosphorus-containing compounds and uses thereof
11/15/2011	US8058305 Pyrrolidine derivatives as prostaglandin modulators
11/15/2011	US8058289 Pyridine methylene azolidinones and use thereof phosphoinositide inhibitors
11/15/2011	US8058282 2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds and compositions for use in therapy
11/15/2011	CA2479126C Combination treatments for chemokine-mediated diseases
11/15/2011	CA2469612C Treatment of statin side effects using uridine derivatives
11/15/2011	CA2449403C Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative bacteria, potential pathogenic gram-positive bacteria
11/15/2011	CA2429979C Treatment of statin side effects
11/15/2011	CA2422031C Ophthalmic solutions comprising difluoroprostaglandin f2 alpha
11/15/2011	CA2399480C Haemophilus influenza outer membrane protein and use thereof in vaccination
11/15/2011	CA2385736C Mediators of hedgehog signaling pathways, compositions and uses related thereto
11/15/2011	CA2171761C Eotaxin: eosinophil chemotactic cytokine
11/10/2011	WO2011138916A1 Polycyclic compound
11/10/2011	WO2011138228A1 Aqueous composition for ophthalmic or dermal use
11/10/2011	WO2011053801A4 Methods and cosmetic preparations for the sustained delivery of therapeutic agents to the eye
11/10/2011	US20110275715 Method for treating retinal disease
11/10/2011	US20110275711 Method for treating macular edema
11/10/2011	US20110275708 Polycyclic compounds and methods related thereto
11/10/2011	US20110275688 Ketorolac compositions for corneal wound healing
11/10/2011	US20110275682 Novel choline cocrystal of epalrestat
11/10/2011	US20110275680 Noxel oxime derivatives of 3, 5-seco-4-nor-cholestane, pharmaceutical compositions containing same, and method for preparing same
11/10/2011	US20110275679 Flupirtine hydrochloride maleic acid cocrystal
11/10/2011	US20110275677 Indole compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (s1p) receptor biological activity
11/10/2011	US20110275650 Methods and compositions related to targeting monoacylglycerol lipase
11/10/2011	US20110275639 C5aR ANTAGONISTS
11/10/2011	US20110275638 Piperazine derivatives and their use as leptin receptor modulators
11/10/2011	US20110275632 Method for preventing or treating a disease related to the glucocorticoid receptor
11/10/2011	US20110275629 Pyridazino-pyridinone Compounds and Methods of Use
11/10/2011	US20110275617 Ophthalmic composition
11/10/2011	US20110275615 Novel substituted amides, their preparation and use
11/10/2011	US20110275603 Novel immunomodulator and anti-inflammatory compounds
11/10/2011	US20110275602 Pharmaceutical association, compositions for topical use, forms of dosage and method of treatment of acute or chronic otitis in pet animals
11/10/2011	US20110275593 Stabilized ophthalmic galactomannan formulations
11/10/2011	US20110275555 Compositions containing delta-9-thc-amino acid esters and process of preparation
11/10/2011	US20110274760 Use of synthetic inorganic nanoparticles as carriers for ophthalmic and otic drugs
11/10/2011	US20110274749 Methods and compositions for targeting agents into and across the blood-brain barrier and other endothelial cell microvascular barriers
11/10/2011	US20110274725 Decomposable biocompatible hydrogels and system and method for using same
11/10/2011	US20110274696 Antibodies to ccr2
11/10/2011	US20110274667 Methods for obtaining cell populations from adipose tissue
11/10/2011	US20110274662 Methods of Producing RPE Cells and Compositions of RPE Cells
11/10/2011	US20110274661 Attentuated Herpesvirus Encoding a Mek Pathway Polypeptide
11/10/2011	US20110274653 Dendritic cell immunoreceptors (dcir)-mediated crosspriming of human cd8+ t cells
11/10/2011	US20110274644 Lens care compositions
11/10/2011	US20110274623 Stabilized Fibronectin Domain Compositions, Methods and Uses
11/10/2011	US20110274620 Multifunctional degradable nanoparticles with control over size and functionalities

1 ... 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 ... 531